Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

Circulation

Volumn 107, Issue 14, 2003, Pages 1884-1890

  Gerber, Ivor L ^a   Stewart, Ralph A H ^a   Legget, Malcolm E ^a   West, Teena M ^a   French, Renelle L ^a   Sutton, Timothy M ^a   Yandle, Timothy G ^b   French, John K ^a   Richards, A Mark ^b   White, Harvey D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Atrial natriuretic factor; Echocardiography; Natriuretic peptides; Stenosis; Valves

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGE FACTORS; ANGINA PECTORIS; AORTIC VALVE STENOSIS; ATRIAL NATRIURETIC FACTOR; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SYNCOPE;

EID: 0037446572     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000060533.79248.0C     Document Type: Article

References (37)

1. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl E):57-64.
2. Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471-483.
3. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(suppl 1):61-67.
4. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br Heart J. 1973;35:41-46.
5. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262-2270.
6. Bonow RO, Carabello B, McCay CR, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 1998;32:1486-1588.
7. Yandle TG, Espiner EA, Nicholls MG, et al. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab. 1986;63:72-79.
8. Yandle TG, Richards AM, Gilbert A, et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993;76:832-838.
9. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997;47:287-296.
10. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509-516.
11. Berger R, Huelsmann M, Strecker K, et al. B-Type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392-2397.
12. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
13. Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J. 2001;142:725-732.
14. Prasad N, Bridges AB, Lang CC, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J. 1997;133:477-479.
15. Talwar S, Downie PF, Squire IB, et al. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001;3:15-19.
16. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
17. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting Diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105:595-601.
18. Reichek N, Wilson J, St John Sutton M, et al. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982;65:99-108.
19. Otto CM, Pearlman AS, Comess KA, et al. Determination of the stenotic aortic valve area in adults using Doppler echocardiography. J Am Coll Cardiol. 1986;7:509-517.
20. Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol. 1990;15:1012-1017.
21. Kelly TA, Rothbart RM, Cooper CM, et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988;61:123-130.
22. STS National Database. STS US Cardiac Surgery Database: 1997 aortic valve replacement patients: preoperative risk variables. Society of Thoracic Surgeons. 1997. 30-7-2002.
23. Gould KL. Why angina pectoris in aortic stenosis. Circulation. 1997;95:790-792.
24. Schwartz LS, Goldfischer J, Sprague GJ, et al. Syncope and sudden death in aortic stenosis. Am J Cardiol. 1969;23:647-658.
25. Carabello BA. Evolution of the study of left ventricular function: everything is old is new again. Circulation. 2002;105:2701-2703.
26. Ikeda T, Matsuda K, Itoh H, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J. 1997;133:307-314.
27. Otto CM. Aortic stenosis: clinical evaluation and optimal timing of surgery. Cardiol Clin. 1998;16:353-373.
28. Otto CM. Aortic stenosis: listen to the patient, look at the valve. N Engl J Med. 2000;343:652-654.
29. Langenickel T, Pagel I, Hohnel K, et al. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am J Physiol. 2000;278:H1500-H1506.
30. Zile MR, Green GR, Schuyler GT, et al. Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy. J Am Coll Cardiol. 2001;37:1080-1084.
31. Boomsma F, van den Meiracker AH. Plasma A-, and B-type natriuretic peptides, physiology, methodology and clinical use. Cardiovasc Res. 2001;51:442-449.
32. Hall C, Rouleau JL, Moyè L, et al. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934-1942.
33. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254-258.
34. Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999;10:537-540.
35. Legget ME, Kuusisto J, Healy NL, et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J. 1996;131:94-100.
36. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992; 86:1099-1107.
37. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001;86:381-386.